These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 4263267)
21. [Decrease of vascular fragility in diabetic retinopathy through calciumdobesilate (author's transl)]. Freyler H; Sehorst W Klin Monbl Augenheilkd; 1974 Feb; 164(2):246-51. PubMed ID: 4842139 [No Abstract] [Full Text] [Related]
22. [The plasma levels of endothelin in diabetic retinopathy and their changes after treatment with doxium]. Zhong H; Guo L Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):56-8. PubMed ID: 9868029 [TBL] [Abstract][Full Text] [Related]
24. [Treatment of diabetic retinopathy and recurrent hemorrhages into the vitreous with calcium dobesilate]. Favre M Ophthalmologica; 1970; 161(4):389-93. PubMed ID: 5483904 [No Abstract] [Full Text] [Related]
25. [Comparative animal experiment studies on the anti-edema effect of O-(beta-hydroxy-ethyl)-rutosides and calcium dobesilate]. Gloor M; Rother H; Friederich HC Z Hautkr; 1974 May; 49(9):393-400. PubMed ID: 4600818 [No Abstract] [Full Text] [Related]
26. [Use of a new synthetic hemostatic in surgical practice: DBSD]. Arsac M Presse Med (1893); 1966 Jan; 74(6):255-6. PubMed ID: 5901693 [No Abstract] [Full Text] [Related]
27. The action of calcium dobesilate on capillary permeability in diabetics. Sévin R; Cuendet JF Ophthalmologica; 1971; 162(1):33-40. PubMed ID: 5547865 [No Abstract] [Full Text] [Related]
28. [On the treatment of vascular fragility appearing during prolonged anticoagulation]. Cloetens W; Colin W; Michel J Angeiologie; 1967; 19(5):53-66. PubMed ID: 5621974 [No Abstract] [Full Text] [Related]
29. [On the treatment of diabetics with reduced vision and blindness. Our opinion on the frequency of blindness in diabetes mellitus]. Brückner R Praxis; 1969 Sep; 58(35):1072-81. PubMed ID: 5820309 [No Abstract] [Full Text] [Related]
30. [Therapy of diabetic retinopathy]. Fossati C Clin Ter; 1979 Dec; 91(6):641-54. PubMed ID: 397036 [No Abstract] [Full Text] [Related]
31. [Action of synthetic derivatives of Congo red. Angiographic study]. Zenatti C Ann Ocul (Paris); 1971 Mar; 204(3):257-70. PubMed ID: 5089202 [No Abstract] [Full Text] [Related]
32. [Diabetic retinopathy]. Karel I Cesk Oftalmol; 1978 Nov; 34(6):445-51. PubMed ID: 363292 [No Abstract] [Full Text] [Related]
33. [Reduction of operative bleeding by a synthetic product: D.B.S.D. Value in general surgery]. Estour E Lyon Med; 1967 Sep; 218(36):367-76. PubMed ID: 5619510 [No Abstract] [Full Text] [Related]
34. [Clinical trial of Doxium tolerance]. Schwaar R Rev Med Suisse Romande; 1971 Feb; 91(2):127-30. PubMed ID: 5579010 [No Abstract] [Full Text] [Related]
35. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats. Rota R; Chiavaroli C; Garay RP; Hannaert P Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173 [TBL] [Abstract][Full Text] [Related]
36. [Study on the antihemorrhagic action of aminaphtone]. Amato G; Pallini C; Marini A; Aliboni E Minerva Stomatol; 1977; 26(2):91-4. PubMed ID: 304152 [TBL] [Abstract][Full Text] [Related]
37. [Utilization of a new synthetic hemostatic, dihydroxy-1,4 benzene sulfonate-3 diethylammonium (dicynone) in ophthalmologic practice with diabetics]. Le Hunsec J; Pierre G Bull Soc Ophtalmol Fr; 1967 Jan; 67(1):192-200. PubMed ID: 5611485 [No Abstract] [Full Text] [Related]